Product Facts
Each sterile strip is impregnated with 1.5 mg. of Lissamine Green
Greenglo
FDA Label NDC 17238-920
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Hub Pharmaceuticals, Inc. for the product Greenglo (NDC 17238-920). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding product facts, indications:, directions for use:, note:, how supplied:, representative packaging:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications:
For use as a diagnostic agent when superficial corneal or conjunctival tissue change is suspected.
Directions For Use:
For best viewing and patient comfort, the Lissamine Green impregnated tip should be moistened with one or two drops of sterile irrigating or saline solution before application. Apply moistened tip to conjunctiva or fornix as required. It is recommended that the patient blink several times after application.
1. Hold package in middle and tear down toward sterile strip
2. Turn over and tear down from other side, taking care not to tear the sterile strip.
3. Grasp each end of package firmly as shown, without touching the sterile strip, and pull apart.
Note:
Not to be used with soft contact lenses. For external use only. Keep out of the reach of childred.
How Supplied:
Dispenser carton containing 100 strips.
Representative Packaging:
17238-920-98: GreenGlo individual Strip (above)
17238-920-11: Dispenser Carton containing 100 strips (above)
* Please review the disclaimer below.
